课题基金 / 基金详情

New Copper and Rhenium Radiopharmaceuticals

New Copper and Rhenium Radiopharmaceuticals
新型铜铼放射性药物
批准号:
DP0452845
负责人:
Prof Paul Donnelly
金额:
$16.69万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-07-30 至 2007-12-31

项目摘要

项目成果

Prof Paul Donnelly的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aims of this project are to provide new metal-based radiopharmaceuticals for the treatment of cancer, and the imaging of cancer and other conditions through the design and engineering of new coordination complexes of rhenium and copper. Various strategies will be used to selectively and specifically target these metal complexes to the desired areas in vivo for non-invasive imaging and therapeutic applications. The most promising candidates will be tested in the appropriate cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heavy Metal Chemistry Goes Nuclear: Radioactive Rhenium and Terbium Agents
  • 批准号:
    DP230100276
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $30.26万
  • 财政年份:
    2023
  • 负责人:
    Prof Paul Donnelly
  • 依托单位:
Discovering New Chemistry and Potential Applications of Metal Tetrapyrroles
  • 批准号:
    DP200100178
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $31.6万
  • 财政年份:
    2020
  • 负责人:
    Prof Paul Donnelly
  • 依托单位:
Gallium, Copper and Metal Fluoride Complexes Designed for Brain Imaging
  • 批准号:
    LP150100656
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $25.39万
  • 财政年份:
    2016
  • 负责人:
    Prof Paul Donnelly
  • 依托单位:
Technetium and Copper Complexes for Diagnostic Imaging of Neurodegeneration
  • 批准号:
    DP160100288
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $26.47万
  • 财政年份:
    2016
  • 负责人:
    Prof Paul Donnelly
  • 依托单位:
海外基金